Sweet Financial Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.61M Sell
16,086
-175
-1% -$27.9K 0.56% 40
2024
Q2
$2.38M Buy
16,261
+3,034
+23% +$451K 0.54% 42
2024
Q1
$2.09M Buy
13,227
+3,054
+30% +$486K 0.48% 45
2023
Q4
$1.59M Sell
10,173
-2,102
-17% -$322K 0.38% 57
2023
Q3
$1.91M Buy
12,275
+204
+2% +$33.7K 0.51% 42
2023
Q2
$2M Buy
12,071
+3,124
+35% +$504K 0.52% 37
2023
Q1
$1.39M Buy
8,947
+2,497
+39% +$403K 0.38% 47
2022
Q4
$1.14M Buy
6,450
+482
+8% +$83.2K 0.33% 49
2022
Q3
$975K Buy
5,968
+351
+6% +$59.4K 0.31% 46
2022
Q2
$997K Buy
5,617
+585
+12% +$104K 0.31% 43
2022
Q1
$892K Buy
5,032
+3,138
+166% +$534K 0.24% 55
2021
Q4
$324K Buy
+1,894
New +$310K 0.13% 101

Other funds holding JNJ

Sweet Financial Partners's JNJ Position: Q3 2024 in Review

Sweet Financial Partners reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q3 2024, selling an estimated $27.9K and leaving 16,086 shares worth $2.61M. The position accounts for 0.56% of the portfolio, ranked #40.

Sweet Financial Partners first reported a position in JNJ in Q4 2021 and has held it in 12 quarters since. 3,889 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.

  • Sweet Financial Partners held 16,086 shares of Johnson & Johnson worth $2.61M as of Q3 2024.
  • Sweet Financial Partners sold 175 Johnson & Johnson shares in Q3 2024, an estimated $27.9K.
  • Johnson & Johnson made up 0.56% of Sweet Financial Partners's portfolio in Q3 2024, its #40 holding.
  • Sweet Financial Partners first reported a position in Johnson & Johnson in Q4 2021 and has held it in 12 quarters since.
  • 3,889 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.

Based on Sweet Financial Partners's 13F filing for Q3 2024, filed 16 Oct 2024.